Regenerative Medicine: On the Vanguard of Health Care

Terzic, Andre; Folmes, Clifford D.; Martinez-Fernandez, Almudena; Behiar, Atta
July 2011
Mayo Clinic Proceedings;Jul2011, Vol. 86 Issue 7, p600
Academic Journal
An introduction is presented in which the editors discuss regenerative medicine which highlights the science and ethics of induced pluripotency.


Related Articles

  • Introduction of Scleroderma-Specific Induced Pluripotent Stem Cells in A Dish: An Unlimited and Available Source for Evaluation of Developmental Defects in Regenerative Medicine. Ranjbar Niavol, F.; Baharvand, H.; Aghdami, N. // Cell Journal (Yakhteh);Summer 2013 Supplement 1, Vol. 15 Issue Sup 1, p72 

    Objective: Scleroderma -one of the important autoimmune diseases- leads to death of endothelial cells as one of the early events of this disease. The lack of repair after the loss of endothelial cells is observed in these patients and although it is a worldwide disease, its cause has remained...

  • Regenerative medicine: Cause for concern? Alderton, Gemma K. // Nature Reviews Cancer;Jul2014, Vol. 14 Issue 7, p453 

    The article focuses on the study depicting the safety concerns of the regenerative medicine which includes induced pluripotent stem cell (iPSC)-derived material leading to the risk of developing cancer.

  • Tbx3: another important piece fitted into the pluripotent stem cell puzzle. Pirity, Melinda K.; Dinnyes, Andras // Stem Cell Research & Therapy;2010, Vol. 1 Issue 2, p1 

    Induced pluripotent stem cells (iPSCs) are novel tools for biomedical research, with a promise for future regenerative medicine applications. Recently, Han and colleagues reported in Nature that T box gene 3 (Tbx3) can improve the quality of mouse iPSCs and increase their germline transmission...

  • Advances and applications of induced pluripotent stem cells. Pietronave, Stefano; Prat, Maria // Canadian Journal of Physiology & Pharmacology;Mar2012, Vol. 90 Issue 3, p317 

    Direct reprogramming of somatic cells into pluripotent cells is an emerging technology for creating patient-specific cells, and potentially opens new scenarios in medical and pharmacological fields. From the discovery of Shinya Yamanaka, who first obtained pluripotent cells from fibroblasts by...

  • Efficient Generation of Transgene-free iPSCs.  // Bioscience Technology;2014, p1 

    The article presents a research study on induced pluripotent stem cells (iPSCs). Topics discussed include huge potential offered by iPSCs for regenerative medicine, disease modeling and drug screening, inefficiency of traditional methods used for iPSC generation, and creation of human and mouse...

  • Analysis of Embryoid Bodies Derived from Human Induced Pluripotent Stem Cells as a Means to Assess Pluripotency. Sheridan, Steven D.; Surampudi, Vasudha; Rao, Raj R. // Stem Cells International;2012, p1 

    Human induced pluripotent stem cells (hiPSCs) have core properties of unlimited self-renewal and differentiation potential and have emerged as exciting cell sources for applications in regenerative medicine, drug discovery, understanding of development, and disease etiology. Key among numerous...

  • Systematic Search for Recipes to Generate Induced Pluripotent Stem Cells. Rui Chang; Shoemaker, Robert; Wei Wang // PLoS Computational Biology;Dec2011, Vol. 7 Issue 12, Special section p1 

    Generation of induced pluripotent stem cells (iPSCs) opens a new avenue in regenerative medicine. One of the major hurdles for therapeutic applications is to improve the efficiency of generating iPSCs and also to avoid the tumorigenicity, which requires searching for new reprogramming recipes....

  • Fibroblast-like cells as an effective feeder for the cultivation and derivation of new lines of human induced pluripotent stem cells. Novosadova, E.; Manuilova, E.; Arsenyeva, E.; Grivennikov, I.; Myasoedov, N. // Doklady Biochemistry & Biophysics;Sep2016, Vol. 470 Issue 1, p353 

    Induced pluripotent stem cells (iPSCs) can be a highly informative model of hereditary and sporadic human diseases. In the future, such cells can be used in substitution and regenerative therapy of a wide range of diseases and for the treatment of injuries and burns. The ability of iPSCs derived...

  • Understanding the Molecular Circuitry of Cell Lineage Specification in the Early Mouse Embryo. Bergsmedh, Anna; Donohoe, Mary E.; Hughes, Rebecca-Ayme; Hadjantonakis, Anna-Katerina // Genes;Sep2011, Vol. 2 Issue 3, p420 

    Pluripotent stem cells hold great promise for cell-based therapies in regenerative medicine. However, critical to understanding and exploiting mechanisms of cell lineage specification, epigenetic reprogramming, and the optimal environment for maintaining and differentiating pluripotent stem...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics